Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Antimicrobial Chemotherapy|December 23, 2021
Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort studyDidi Bury, Tom F W Wolfs, Rob Ter Heine, et al.
Clinical Pharmacokinetics|May 26, 2017
Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer PatientsLena Klopp-Schulze, Markus Joerger, Sebastian G Wicha, et al.
Clinical Pharmacokinetics|January 24, 2019
Personalized Tuberculosis Treatment Through Model-Informed Dosing of RifampicinStijn W van Beek, Rob Ter Heine, Ron J Keizer, et al.
European Journal of Clinical Pharmacology|March 17, 2019
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adultsDidi Bury, Rob Ter Heine, Ewoudt M W van de Garde, et al.
Pharmacoeconomics - Open|January 28, 2025
Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung CancerLeila-Sophie Otten, Alessandra I G Buma, Berber Piet, et al.
Clinical Pharmacokinetics|February 22, 2021
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary TuberculosisStijn W van Beek, Rob Ter Heine, Jan-Willem C Alffenaar, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
British Journal of Clinical Pharmacology|June 14, 2026
Exploring individualized crovalimab dosing in PNH through in silico modelling: Potential for improved convenience and cost efficiencyMendy Ter Avest, Simon E Koele, Nicole C A J van de Kar, et al.
British Journal of Clinical Pharmacology|November 17, 2022
Dose optimalization of subcutaneous ravulizumab is predicted to yield significant savings and to improve patient friendlinessMendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens, et al.
Annals of Hematology|March 7, 2024
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplanMendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens, et al.
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|December 23, 2021
Pharmacokinetic evaluation of twice-a-week micafungin for prophylaxis of invasive fungal disease in children with acute lymphoblastic leukaemia: a prospective observational cohort studyDidi Bury, Tom F W Wolfs, Rob Ter Heine, et al.
Clinical Pharmacokinetics|May 26, 2017
Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer PatientsLena Klopp-Schulze, Markus Joerger, Sebastian G Wicha, et al.
Clinical Pharmacokinetics|January 24, 2019
Personalized Tuberculosis Treatment Through Model-Informed Dosing of RifampicinStijn W van Beek, Rob Ter Heine, Ron J Keizer, et al.
European Journal of Clinical Pharmacology|March 17, 2019
The effect of neutropenia on the clinical pharmacokinetics of vancomycin in adultsDidi Bury, Rob Ter Heine, Ewoudt M W van de Garde, et al.
Pharmacoeconomics - Open|January 28, 2025
Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung CancerLeila-Sophie Otten, Alessandra I G Buma, Berber Piet, et al.
Clinical Pharmacokinetics|February 22, 2021
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary TuberculosisStijn W van Beek, Rob Ter Heine, Jan-Willem C Alffenaar, et al.
Clinical Pharmacokinetics|March 27, 2024
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of PosaconazoleAnouk M E Jansen, Kim Snijdelaar, Ron J Keizer, et al.
British Journal of Clinical Pharmacology|June 14, 2026
Exploring individualized crovalimab dosing in PNH through in silico modelling: Potential for improved convenience and cost efficiencyMendy Ter Avest, Simon E Koele, Nicole C A J van de Kar, et al.
British Journal of Clinical Pharmacology|November 17, 2022
Dose optimalization of subcutaneous ravulizumab is predicted to yield significant savings and to improve patient friendlinessMendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens, et al.
Annals of Hematology|March 7, 2024
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplanMendy Ter Avest, Saskia M C Langemeijer, Nicole M A Blijlevens, et al.
Pageof 16